| Bioactivity | Antitumor agent-102 (compound 10) is a conjugate of Topoisomerase I inhibitor SN38 and glucose transporter inhibitor, targeting to colorectal cancer. Antitumor agent-102 induces higher concentrations of free SN38 in tumor tissues than Irinotecan (HY-16562)[1]. |
| Name | Antitumor agent-102 |
| Formula | C70H82N8O18S |
| Molar Mass | 1355.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Chiu PF, et al. Design, Synthesis, and Evaluation of Glucose Transporter Inhibitor-SN38 Conjugates for Targeting Colorectal Cancer. J Med Chem. 2023 Jul 6. |
Antitumor agent-102
CAS: F: C70H82N8O18S W: 1355.51
Antitumor agent-102 (compound 10) is a conjugate of Topoisomerase I inhibitor SN38 and glucose transporter inhibitor, ta
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.